Skip to main content
    T

    Trinity Biotech plc (TRIB)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $7.93
    +1.32 (+19.97%)

    Market Cap: $5.12M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    42%(15/36)
    Avg Surprise
    -912.16%
    PeriodReportedEst.SurpriseB/MYoY
    Mar 26
    Reported Apr 30
    		$-28.12N/AN/ABeat-2168.1%
    Dec 25
    Reported Apr 30
    		$-0.90$-0.32-181.25%Miss+96.6%
    Sep 25
    Reported Dec 23
    		$-0.40$0.00N/AMiss+96.9%
    Jun 25
    Reported Jul 1
    		$-14.40$-17.10+15.79%Beat-2.9%
    Mar 25
    Reported May 15
    		$-1.24$-0.05-2380.00%Miss+65.4%
    Dec 24
    Reported Jan 29
    		$-26.35$-9.00-192.75%Miss-14955.5%
    Sep 24
    Reported Nov 15
    		$-12.77$-16.20+21.17%Beat+57.6%
    Jun 24
    Reported Aug 13
    		$-14.00$-19.50+28.21%Beat+43.5%
    Mar 24
    Reported May 22
    		$-3.59$-0.12-2890.67%Miss-5881.3%
    Dec 23
    Reported Jan 31
    		$-0.17$-0.14-25.00%Miss+99.4%
    Sep 23
    Reported Oct 3
    		$-30.12$-13.50-123.11%Miss-291.2%
    Jun 23
    Reported Jul 5
    		$-24.78$-9.00-175.33%Miss-82500.0%
    Mar 23
    Reported Apr 10
    		$-0.06$-0.06+0.00%Beat+99.5%
    Dec 22
    Reported Mar 23
    		$-27.75$-9.00-208.33%Miss-46150.0%
    Sep 22
    Reported Dec 15
    		$-7.70$-6.00-28.33%Miss-182.8%
    Jun 22
    Reported Jul 21
    		$-0.03$-0.03+0.00%Beat-100.1%
    Mar 22
    Reported Apr 11
    		$-11.73$-6.00-95.50%Miss-11830.0%
    Dec 21
    Reported Mar 23
    		$-0.06$0.07-185.71%Miss-100.1%
    Sep 21
    Reported Dec 15
    		$9.30$12.00-22.50%Miss-82.7%
    Jun 21
    Reported Sep 9
    		$30.45$10.50+190.00%Beat+663.9%
    Mar 21
    Reported May 25
    		$0.10$0.07+42.86%Beat+88.7%
    Dec 20
    Reported Mar 25
    		$53.85$21.00+156.43%Beat+298.9%
    Sep 20
    Reported Nov 17
    		$53.70$15.00+258.00%Beat+7060.0%
    Jun 20
    Reported Aug 25
    		$-5.40$-0.02-26900.00%Miss-13600.0%
    Mar 20
    Reported May 27
    		$0.05$0.03+76.67%Beat-92.9%
    Dec 19
    Reported Mar 31
    		$13.50$9.00+50.00%Beat+19185.7%
    Sep 19
    Reported Oct 16
    		$0.75N/A-91.67%Miss-61.5%
    Jun 19
    Reported Aug 20
    		$0.04$0.07-42.86%Miss-99.1%
    Mar 19
    Reported May 7
    		$0.75N/A-92.86%Miss-85.3%
    Dec 18
    Reported Mar 7
    		$0.07$0.04+75.00%Beat-12.5%
    Sep 18
    Reported Oct 23
    		$1.95N/A-78.33%Miss-80.2%
    Jun 18
    Reported Jul 19
    		$4.35N/A-51.67%Miss-6.5%
    Mar 18
    Reported Apr 20
    		$5.10$7.50-32.00%Miss+332.2%
    Dec 17
    Reported Mar 7
    		$0.08$0.07+14.29%Beat-63.6%
    Sep 17
    Reported Oct 26
    		$9.85$8.50+15.88%Beat-
    Jun 17
    Reported Jul 20
    		$4.65$7.50-38.00%Miss-
    Mar 17
    Reported Apr 27
    		$1.18N/A-73.78%Miss-
    Dec 16
    Reported Mar 14
    		$0.22N/A+127.50%Beat-

    Dividends

    Dividend Metrics

    Forward Yield0.00%
    Forward Annual Dividend$0.00
    No dividend payments in the selected period.

    Key Metrics

    Valuation
    P/E Ratio-0.01EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-85.40%Operating Margin-9.98%
    ROE-1913.00%ROIC-14.34%
    Financial Health
    Debt/Equity-1.92xInterest Coverage-0.30x
    Current Ratio0.25xQuick Ratio0.12x
    Trading Statistics
    Beta0.97Avg Volume13.78K
    52-Week High$52.5052-Week Low$5.01

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$6.57
    SMA 20$6.73
    SMA 50$8.70
    SMA 200$16.25
    EMA 10$6.80
    EMA 20$6.99
    EMA 50$8.47
    EMA 200$15.04

    MACD

    Line: -0.45Signal: -0.69Hist: 0.24

    ADX

    ADX: 16.5+DI: 21.7-DI: 15.4

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down60.0
    PSAR$5.48

    Bollinger Bands

    Upper Band$7.83
    Lower Band$5.62
    %B Position3288%(Upper)
    Band Width1.04

    RSI (14-Day)

    Neutral
    55.5

    Momentum Oscillators

    Stoch %K65.0
    Stoch %D60.2
    Williams %R-12.8
    ROC (10d)25.5%
    Momentum1.61
    CCI (20d)135.4
    MFI (14d)65.9

    Volatility Measures

    ATR (14d)$1.14(14.4%)
    StdDev (20d)0.55
    Hist Vol141.1%(High)

    Volume Flow

    VWAP$7.50
    OBV406.9M
    AD Line116.2B
    CMF (20d)-0.031

    Volume Metrics

    Avg Vol (20d)13.6K
    Vol Ratio2.0x(High)
    VWMA (20d)$6.81

    Pivot Points

    R3$8.12
    R2$7.66
    R1$7.14
    Pivot Point$6.68
    S1$6.15
    S2$5.69
    S3$5.17

    Advanced Oscillators

    TSI-18.04
    Ultimate Osc41.6
    KST-222.71

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$11.06M$11.06M$14.25M$10.98M$7.58M$15.86M$15.15M$15.84M$14.70M$14.70M$14.68M$13.90M
    Cost of Revenue$7.52M$7.52M$8.16M$6.65M$6.01M$10.98M$9.84M$10.11M$9.71M$9.71M$10.40M$8.87M
    Gross Profit$3.55M$3.55M$6.09M$4.33M$1.57M$4.88M$5.31M$5.73M$5.00M$5.00M$4.28M$5.03M
    Operating Expenses$6.49M$6.49M$6.62M$7.37M$6.30M$16.39M$7.87M$17.51M$8.06M$8.06M$8.78M$9.07M
    R&D$1.06M$1.06M$813,311$646,537$1.12M$1.45M$1.01M$991,000$1.09M$1.09M$1.17M$1.23M
    SG&A$0$5.43M$0$6.73M$0$8.37M$6.52M$6.42M$7.50M$6.93M$7.68M$7.91M
    Operating Income$-2,942,818$-2,942,818$-536,566$-3,043,185$-4,732,535$-11,514,000$-2,558,000$-1,667,000$-3,041,000$-3,070,000$-4,500,000$-14,852,000
    Interest Income$0$-999$0$0$0$903,000$848,000$0$55,000$605,000$389,000$62,000
    Interest Expense$12.66M$12.66M$4.27M$2.15M$2.31M$4.28M$3.08M$5.42M$264,000$264,000$2.39M$3.82M
    Income Before Tax$-17,636,926$-17,636,926$-5,039,143$-5,748,914$-8,797,572$-15,798,000$-4,794,000$-6,888,000$-3,250,000$-3,250,000$-6,498,000$-18,613,000
    Income Tax Expense$-173,871$-173,871$72,670$297,934$0$585,000$-35,000$0$67,000$67,000$222,000$-267,000
    Net Income$-17,463,055$-17,463,055$-5,111,814$-6,046,849$-8,803,576$-16,956,000$-4,759,000$-6,757,000$-3,317,000$-3,317,000$-6,721,000$-5,988,000
    EBITDA$-2,214,358$-2,214,358$120,453$-2,377,394$-4,094,059$-9,598,000$-1,112,000N/A$-2,295,000$-2,295,000$-3,882,000$-14,306,000
    EBIT$-2,942,818$-2,942,818$-536,566$-3,043,185$-4,732,535$-10,022,000$-1,710,000N/A$-2,986,000$-2,986,000$-4,111,000$-14,790,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TRIB

    News

    Trinity Biotech reported 95 percent AGM support for Trinity Biotech stock

    Trinity Biotech shareholders approved all resolutions at their annual general meeting on September 30, 2026, with at least 95 percent support...

    ad-hoc-news.de•10/15/26•Somewhat-Bullish

    Total common shares outstanding of Trinity Biotech Plc Sponsored ADR Class A – GETTEX:TRB0

    This article provides financial data for Trinity Biotech Plc Sponsored ADR Class A (GETTEX:TRB0), specifically focusing on its total common shares outstanding. It presents this information within the TradingView...

    TradingView•10/12/26•Neutral

    Total debt of Trinity Biotech Plc Sponsored ADR Class A – GETTEX:TRB0

    This page displays the total debt of Trinity Biotech Plc Sponsored ADR Class A under the GETTEX:TRB0 ticker. The company's financials, including total debt, are presented...

    TradingView•10/6/26•Neutral

    Trinity Biotech stock gained 21.32 percent on October 5, 2026

    Trinity Biotech stock rose by 21.32% on October 5, 2026, closing at USD 7.00 after shareholders approved all resolutions at the September 30 annual general meeting. Despite this gain...

    AD HOC NEWS•10/5/26•Somewhat-Bullish

    Trinity Biotech Reports Unanimous Shareholder Approval at 2026 AGM

    Trinity Biotech plc announced that all proposed resolutions were unanimously approved by shareholders at its annual general meeting on September 30...

    Kalkine Media•10/5/26•Bullish

    TRIB Valuation and Fair Value

    P/E
    -0.0x
    Forward P/E
    4.5x
    PEG
    0.3x
    P/B
    -0.1x
    See GNG's fair value

    TRIB Profitability: Margins, ROIC and FCF

    Gross margin
    37.0%
    Operating margin
    -10.0%
    Net margin
    -85.4%
    ROIC
    -14.3%
    ROE
    -1913.0%
    FCF margin
    -10.2%

    TRIB Competitors

    CompanyTicker
    Aptorum Group Ltd Class AAPM
    Icecure MedicalICCM
    Processa Pharmaceuticals IncPCSA
    Pulmatrix IncPULM
    Volitionrx LtdVNRX
    Sonnet Biotherapeutics Holdings IncSONN
    Scienture Holdings, Inc.SCNX
    Biomx IncPHGE

    Sector: Healthcare

    TRIB Bull Case vs Bear Case

    Bear case

    • TRIB has a -85.4% net profit margin.
    • TRIB beat EPS estimates in 37.5% of its last 8 reported quarters.
    • TRIB's quarterly revenue changed -5.5% year over year.

    TRIB Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -797.1%

    TRIB Dividend

    Forward yield
    0.0%

    Frequently Asked Questions About TRIB

    Does TRIB pay dividends?

    Trinity Biotech plc (TRIB) has a dividend payment track record. See the TRIB dividend history page for its current payment status, TTM yield, and recorded payments.

    What is TRIB's market cap?

    Trinity Biotech plc (TRIB) has a market capitalization of $5.12M with a current stock price of $7.93.

    Related stocks

    Sector: Healthcare

    All stocks starting with T

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In